ライフサイエンスコーパス: cervical cytology

1 d again in 2001 from 1,775 women with normal cervical cytology.

2 tem terminology for reporting the results of cervical cytology.

3 y and correlated the results with concurrent cervical cytology.

4 ound in up to 40% of young women with normal cervical cytology.

5 Cervical cytology abnormality following either HPV vacci

6 In this observational study, all cervical cytology and HPV testing reports from January 1

7 coplasma genitalium and its association with cervical cytology and other correlates, we recruited 350

8 Women were assessed for HPV infection by cervical cytology and self-obtained cervicovaginal sampl

9 -16 variants at a high viral load), abnormal cervical cytology, and SIL.

10 DNA, using cervical samples, and did yearly cervical cytology assessments.

11 , 88%-94%]) HIV-uninfected women with normal cervical cytology at enrollment.

12 men and 279 HIV-uninfected women with normal cervical cytology at their enrollment in a multi-institu

13 cted in 15 of 37 (40.5%) women with abnormal cervical cytology but in only 4 of 35 (11.4%) women with

14 of residual specimens collected for routine cervical cytology can help identify those who have under

15 t testing for human papillomavirus (HPV) and cervical cytology (co-testing) is an approved alternativ

16 rkov model as part of a systematic review of cervical cytology conducted at the Duke University Evide

17 Routine clinical data included anal and cervical cytology, demographic/behavioral data, and high

18 nique, the new Bethesda system for reporting cervical cytology findings, and several recent professio

19 primary cervical screening, as an adjunct to cervical cytology for the management of low grade abnorm

20 IN), which resembled human CIN by endoscopy, cervical cytology, histology, and immunohistochemistry.

21 Regular cervical cytology is critical due to a recognized increa

22 The standard for reading cervical cytology is for a cytoscreener to manually sear

23 The routine practice of cervical cytology is limited by problems of false negati

24 A tests have been approved only for abnormal cervical cytology management and as an adjunct to cervic

25 ho were healthy, with no history of abnormal cervical cytology, no previous abnormal cervical biopsy

26 reflex HPV DNA testing, a strategy of repeat cervical cytology or delayed HPV testing costs more but

27 m 3 years to 5 years among those with normal cervical cytology (Pap test) results who test negative f

28 prove health; strong indirect evidence links cervical cytology programmes to declines in cervical can

29 The detection rate for an abnormal cervical cytology result during the observation period w

30 The risk for an abnormal cervical cytology result was lower among vaccinated vs u

31 demographics, clinic type, abnormal baseline cervical cytology result, and baseline Chlamydia screeni

32 Seven women reported abnormal cervical cytology results after transplantation.

33 rated vaccine effectiveness against abnormal cervical cytology results.

34 helial neoplasia (CIN2+) in a total of 8,610 cervical cytology samples from the ARTISTIC population-b

35 gies for cervical cytology screening, proper cervical cytology sampling technique, the new Bethesda s

36 l recent professional society guidelines for cervical cytology screening and management of cytologic

37 We estimate that cervical cytology screening of all women aged 55-79 year

38 We sought to quantify the efficacy of cervical cytology screening to reduce death from this di

39 ny HIV-infected women do not undergo routine cervical cytology screening, however, and there are curr

40 men, the development of new technologies for cervical cytology screening, proper cervical cytology sa

41 cal cytology management and as an adjunct to cervical cytology screening.

42 ugh 20 years of age and underwent subsequent cervical cytology screening.

43 l copy number changes directly in thin-layer cervical cytology slides by fluorescence in situ hybridi

44 s of the Inv2 test in the screening of ASCUS cervical cytology specimens and correlates the results o

45 population-based stratified sample of 59 664 cervical cytology specimens from women residing in New M

46 more often than in HIV-seropositive abnormal cervical cytology than uninfected ones and were more lik

47 V-16-infected women with normal and abnormal cervical cytologies to obtain evidence of active infecti

48 R HPV infections; the prevalence of abnormal cervical cytology was 38% among women who were HR HPV-po